Information
on this page was adapted from the Vaccine-Preventable
Disease Surveillance Manual, 3rd Edition,
2002, Chapter 7, Mumps: p.5-7 (except
where noted in red text below.)
Reporting
Each state and territory has regulations or laws governing the reporting of diseases and conditions of public health importance. These regulations and laws list the diseases that are to be reported and describe those persons or groups responsible for reporting, such as health-care providers, hospitals, schools, laboratories, daycare and childcare facilities, and other institutions.
Contact the state health department for reporting requirements in your state. You can find the contact information for your state health department at the following website: http://www.cdc.gov/doc.do/id/0900f3ec80226c7a
Reporting
to CDC
A provisional report of probable, and confirmed cases should be sent to the National Notifiable Diseases Surveillance System by the state health department via the National Electronic Telecommunications System for Surveillance (NETSS) or National Electronic Disease Surveillance System (NEDSS). Reporting should not be delayed because of incomplete information or lack of confirmation; following completion of case investigations, data previously submitted to NETSS or NEDSS should be updated with the available new information.
Information
to collect UPDATED Nov 6, 2006
A detailed case investigation of each case should be conducted. Basic demographic information (age, race or ethnicity, sex, county, and country of birth), date of onset of symptoms, and mumps vaccination history allow cases to be characterized and also allow identification of groups at increased risk of disease.
The
following data elements are epidemiologically
important and should be collected
in the course of a case investigation.
Additional information may be collected
at the direction of the state health
department.
Demographic
Information UPDATED
Nov 6, 2006
- Name
- Address
- Date
of birth
- Age
- Sex
- Ethnicity
- Race
- Country
of birth
- Length
of time in U.S.
Reporting
Source UPDATED
Nov 6, 2006
- County
- Earliest
date reported
Clinical UPDATED
Jan 5, 2007
- Date
of illness onset, especially parotitis
- Duration
of parotitis
- Spectrum
of symptoms
- Parotitis
or other salivary gland involvement
(only pain, tenderness, swollen)
- Other
symptoms (e.g., headache, anorexia,
fatigue, fever, body aches,
stiff neck, difficulty in swallowing,
nasal congestion, cough, earache,
sore throat, nausea, abdominal
pain)
- Hospitalizations and duration of stay - association to mumps
- Complications
- Meningitis
- Deafness (transient or permanent)
- Encephalitis
- Orchitis
- Other
- Outcome
(case survived or died)
- Postmortem
examination results
- Death
certificate diagnosis
Treatment UPDATED
Jan 5, 2007
- Medications
given
- Duration
Laboratory UPDATED
Nov 6, 2006
Vaccine Information UPDATED
Nov 6, 2006
- Dates
of mumps vaccination
- Number
of doses of vaccine given
- Manufacturer
of vaccine
- Vaccine
lot number
- If
not vaccinated, reason
Epidemiological UPDATED
Jan 5, 2007
- Epi-Linkages
- Transmission
setting (e.g., college)
- Source
of transmission
- Source
of exposure
- Import
status*
- Travel
history
*An
internationally imported case is defined
as a case in which mumps results from
exposure to mumps virus outside the
United States (U.S.) as evidenced
by at least some of the exposure period
(12-25 days before onset of symptoms)
occurring outside the U.S.
and symptom onset occurring within
25 days of entering the U.S.
and there is no known exposure to
mumps in the U.S. during that time.
 Return
to Mumps Main Page
|
